Khellin, a naturally occurring furanochromone (Ammi visnaga fruits), inhibited the mutagenicity of the promutagens benzo[a]pyrene, 2-aminofluorene and 2-aminoanthracene in Salmonella typhimurium TA98. The effect varied greatly and depended on the S9 fraction used. Cytosolic activation of 2-aminoanthracene was also inhibited. Khellin produced no effect or only weak activity against the direct acting mutagens 2-nitrofluorene, 4-nitro-o-phenylenediamine, 1-nitropyrene and ethyhnethane sulfonate (in TA100). Daunomycin mutagenicity was inhibited to a greater extent Visnagin was more toxic, but showed similar effects. Khellol and its glucoside were inactive against all the mutagens tested. We conclude that khellin acts as an inhibitor of the microsomal cytochrome P450 sub-enzymes analogous to the related furanocoumarins and is also capable of inhibiting cytosolic enzymes. The extract from Ammi visnaga fruits showed a higher inhibition potency than khellin alone against 2-aminoanthracene, 1-nitropyrene and daunomycin. This might be due to additional inhibitors, e.g. coumarins, or to the synergistic effects of accompanying compounds.
Introduction
Within the medicinal plants used today the occurrence of furanochromones is mainly restricted to Ammi visnaga (Apiaceae). The seeds of the plant accumulate khellin, visnagin and khellol glucoside (chemical structures in Figure 1 ), together with small amounts of pyranocoumarins, e.g. visnadin. Khellin is considered to be one of the active principles. It is present at an average concentration of ~1% in the seeds. Khellin shows spasmolytic effects and is reported to be a moderate photochemotherapeutic agent with lower phototoxic side effects than furanocoumarins (Abdel Fattah, 1983; HOnigsmann and Ortel, 1985) . Owing to the similarity of their chemical structures and photobiological behaviour, one may expect furanochromones and furanocoumarins to exhibit further common properties. Indeed, representatives from both groups show anti-mutagenic potencies in Salmonella typhimurium. The antimutagenic effect of furanocoumarins was demonstrated by Wall et al. (1988) , Schimmer et al. (1991) and Edenharder etal. (1995) . The furanochromone khellin was recently reported to be a very active anti-mutagen against the heterocyclic amine 2-amino-3-methylimidazo [4, , which is generated under normal cooking conditions from protein in food (Edenharder et al., 1995) . The inhibitory effect of both groups was suggested to proceed via the cytochrome P450 isoenzymes.
If this conclusion is valid and inhibition of monooxygenases is the only mechanism of action one might expect that khellin would also be active against other promutagens, but be without any effect against direct acting mutagens.
It was the aim of our study to test this assumption and to gain basic information on the anti-mutagenicity spectrum of furanochromones.
Material and methods

Chemicals
Visnagin and khellolglucoside were purchased from C.Roth (Karlsruhe); khellin, 1-nitropyrene (1-NP), 2-nitrofluorene (2-NF), 4-nitro-o-pbenylenediamine (4-NOPD), benzo[a]pyrene (B[a]P) from Aldrich-Chemie (Steinheim). 2-Aminoanthracene (2-AA), 2-aminofluorene (2-AF), ethylmethane sulfonate (EMS), 3-methylcholanthrene (MC), fi-naphthoflavone (BNF) and corn oil were obtained form Sigma Chemie (Deisenhofen). Phenobarbital (PB) was from Bayer (Leverkusen) and daunomycin from Fluka (Buchs, Switzerland). The pyranocoumarin visnadin was a generous gift from Dr A.G.Madaus (Kola).
All commercial compounds tested for anti-mutagenicity were of the highest purity grade available.
Plant extract
The Ammi visnaga fruit extract was a generous gift from Dr K.G.Hetterich (FUrth). It was designed as an extractum Ammeos visnagae fluidum (1:1), Ch.B. 02740096, and processed in accordance with the guidelines of the German Pharmacopoeia.
Petroleum ether fraction
The commercial plant product was extracted three times with petroleum ether (b.p. 30-50°). The organic phases were concentrated and divided into two parts. After evaporation under reduced pressure one part was dissolved in ethanol for TLC analysis; the second part was dissolved in dimethylsulfoxide (DMSO) and used for the anti-mutagenicity test TLC: silica gel 60 F254; solvent, ethylacetate; detection, UV2J4 and UV^. Conditions were as under 'Quantitative estimation of khellin' below. Khellin, visnagin and visnadin were used as reference compounds.
Khellol
Khellol was prepared from khellol glucoside as follows. Khellol glucoside was treated with 1 M HC1 at 95°C for 30 min. The hydrolysate was extracted five times with ethylacetate and the organic phases collected and evaporated to dryness. The residue was dissolved in ethanol and chromatographed on preparative silica gel plates, with ethylacetate as solvent. The khellol zones (detection UV2J4) were scraped off and eluted with methanol. After centrifugation the methanol was removed and the residue dried and stored at room temperature.
Quantitative estimation of khellin
The Ammi visnaga extract was diluted with 10% ethanol and 100, 200 and 400 nl samples were chromatographed on pre-coated silica gel F234 plates (Merck) with ethylacetate as solvent. The khellin zones (detection UV254) were scraped off, poured into test tubes and treated with 3.00 ml 5 M sulfuric acid at 60° C for 5 min. The reaction mixture was centrifiiged and the absorption of the yellow supernatant was measured at 405 nm (SP 8-400; Pye-Unicam). The concentration of khellin was calculated using a standard curve produced with authentic material. The khellin content was 1.00 ± 0.08 mg/100 uJ extract (average of four separate estimations).
Anti-mutagenicity testing
If not stated otherwise, the experiments were performed using the standard plate incorporation method described by Maron and Ames (1983) with Salmonella typhimurium TA98 and TA100 as tester strains. The test compounds
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were dissolved in DMSO and added to the top agar together with the mutagen and the bacteria plus S9 mix. The test compounds were examined at doses of 50-1000 ng/plate or up to doses where toxic effects were manifest The extract was tested at 10-100 nl/plate, which is equivalent to 100-1000 u.g khellin/plate.
The mutagens were dissolved in DMSO and used at fixed doses which induced the number of revertants per plate (± SD) as summarized in Table  I . The number of spontaneous revertanls were 15-28/plate (TA98 -S9), 25-44/plate (TA98 + S9) and 119 ± 12 (TA100 -S9). 59 fractions S9 fractions were prepared from male Wistar rats (200-300 g body wt) which were treated l.p. daily with PB (70 mg/kg), MC (25 mg/kg) or BNF (80 rag/ kg) respectively for 3 days. The control group received only corn oil (0 5 ml) and was regarded as uninduced (UN). Four days after the first injection the animals were killed by cervical dislocation The animals were starved for 24 h immediately preceding death. The protein contents of the S9 fractions were 29 (PB), 30 (MC), 32 (UN) and 30.8 (BNF) mg/ml respectively and were adjusted to 30 mg/ml The cytochrome P450 levels were 0 37 ± 0.01 nmol/ mg protein (PB), 0.15 ± 0.005 (MC), 0 11 ± 0.005 (UN) and 0.14 ± 0.005 (BNF) respectively.
S9 mix
One millilitre of the standard S9 mix contained 0.1 ml S9 fraction, 0.1 ml 70 mM MgSO 4 , 0.1 ml 40 mM NADP, 0.1 ml 200 mM D,i_-isocitrate and 0 6 ml 100 mM phosphate buffer, pH 7.4. The protein content was estimated by the method of Lowry el al (1951) , cytochrome P450 was determined by the method of Omura and Sato (1964) .
Data evaluation
The data are the mean of two separate experiments, each on quadruplicate plates, if not indicated otherwise The spontaneous rcvertants have been subtracted The number of revertants/plate induced by the mutagens without inhibitor are summarized in Table I Calculation of percent inhibition and evaluation of toxicity have been described earlier (Schimmer and Lindenbaum, 1995) . 
Results
Khellin inhibited the mutagenicity of the three promutagens in a dose-dependent manner, but to different degrees ( Figure  2 ). Based on the ID50 value of 70 fig/plate, which was equivalent to 269 nmol/plate, khellin was a very active inhibitor of the mutagenicity of B[a]P. Nevertheless, a 13.5-fold molar excess of the inhibitor was needed to reduce the mutagenic effect of 5 (ig B[a]P, i.e. 19.8 nmol/plate, by 50%. This ratio was observed when S9 from BNF-pretreated rats was utilized. With S9 from MC-pretreated rats, however, four times more khellin was required to obtain a 50% reduction in mutagenicity (Table II) . Khellin showed a similar inhibitory effect against 2-AF + S9 (PB-induced) (Figure 2) . However, when compared at equimolar levels a 245-fold molar excess of the inhibitor was necessary for 50% inhibition. S9 mix from MC-pretreated rats produced only a limited metabolic activation of 2-AF, which was not inhibited by khellin.
The highest degree of variation was found when khellin The data are the mean of one or two separate experiments on quadruplicate plates "Corresponding control data to Figure 3 b Corresponding control data to Figure 2 and Tables II and III The data from the expenments with visnagin and extract are given in parentheses.
was tested against 2-AA. No effect was detected when 2-AA was activated by MC-or BNF-induced S9, although mutation induction was very efficient A weak effect was obtained when S9 from PB-pretreated rats were used. However, with S9 from uninduced rats the mutagenicity of 2-AA was strongly inhibited by khellin (Figure 3 ). An IDso of 90 |lg/plate was calculated from the dose-effect curve.
No attempt was made to analyse metabolic activation of the promutagens in relation to S9 concentration. Therefore, we cannot exclude the possibility that in some experiments suboptimal S9 doses were applied.
Mutagens and promutagens can also be activated by cytosolic For the corresponding number of revertants/plate without inhibitor see Table  I . NT, not tested "No inhibition within the dose range tested was found with MC-induced S9.
•Toxic at doses of >200 |lg/plate. c 100 uJ of extract contained 1000 (Ig khellin (see Materials and Methods).
preparations. Cytosolic enzymes are at least partly responsible for activation of aristolochic acid II and related nitro aromatic compounds (Schimmer and Drewello, 1994) . Cytosol can also readily activate 2-AA in the absence of microsomes (Forster et al, 1981; Ayrton et al., 1992; de Flora et al., 1994) . Therefore, experiments were carried out to determine activation of 2-AA in vitro by cytosolic preparations from uninduced as well as from PB-induced rats. Khellin was capable of inhibiting metabolic activation by cytosol to a comparable degree in both series (ID^ ~ 100 ^.g/plate; Figure 4 ). It should be noted that the activation effect of cytosol was lower than that of S9. However, this may be caused by the fact that we did not use freshly prepared liver homogenate. When tested against the promutagens visnagin showed a similar pattern of inhibition as khellin. Owing to its high toxicity, only a small dose range could be examined (Table  H) . Khellol and khellol glucoside showed no effect against promutagens plus S9 nor against some direct acting mutagens (data not shown).
The mutagenicity of direct acting mutagens was apparently less affected by khellin. Generally, inhibitory effects of khellin against direct acting mutagens were absent or weak at doses up to 1000 jig/plate (Table 111) . Only daunomycin-mediated mutagenicity was markedly reduced by khellin.
This exceptional characteristic of daunomycin within the direct acting mutagens was still more pronounced when the commercial Ammi extract was applied as an inhibitor (Table  HI) . Similarly, 1-NP mutagenicity was more inhibited by the extract than by khellin (Table HI) For the corresponding number of revertants/plate without inhibitor see Table I . "100 |il of extract are equivalent to 1000 u,g khellin as calculated from quantitative determinations.
•"In a single experiment no significant inhibition was observed any activity against 2-NF and a weak effect against 4-NOPD, but was very active against the promutagens 2-AF and 2-AA (Table II) . While the inhibitory effect against 2-AF was very similar for both plant products, as demonstrated by the similar ED5o values, the extract was more effective in inhibiting 2-AA + S9 (PB-induced) mutagenicity than khellin alone (Table I) .
Discussion
The promutagens used as model mutagens in this study differ in their mode of activation. B[a]P is converted by cytochrome P450 enzymes into benzo[a]pyrene diol epoxide (Sims et al., 1974) . 2-AF is metabolized into hydroxylamines and esters as ultimate mutagens. This activation is also catalyzed by cytochrome P450 enzymes (Frederick et al., 1982) . In both cases the inhibitory effect of khellin is possibly caused by inactivation of certain sub-enzymes of the cytochrome P-450 complex. This agrees well with conclusions from the work of Edenharder et al. (1995) . They found that khellin and the related furanochromone visnagin strongly inhibited the mutagenicity of the promutagen IQ, which is activated by microsomal enzymes via A'-hydroxylation. They further showed that khellin probably acts by the same mechanism as the chemically related furanocoumarins, affecting cytochrome P450 sub-enzymes and therefore preventing A'-hydroxylation. The reactive site is probably the furan double bond, as suggested in the case of furanocoumarins (Wilkinson and Fry, 1995) . However, we cannot totally rule out an interaction between the inhibitor and reactive intermediates produced by the promutagens.
In the exceptional case of 2-AA we have to take into account the possibility that several pathways may lead to activation. In addition to the cytochrome P450 system, other microsomal enzymes, such as FAD monooxygenase, may have substantial effects (Pelroy and Gandolfi, 1980) . In the cytosolic pathway DT diaphorase seems to play an important role (de Flora et al., 1994) . This enzyme is efficiently inhibited by dicoumarol (Ernster et al., 1962) , and possibly by other coumarins which exhibit anti-mutagenic effects against 2-AA ( Wall et al., 1988) . Inhibition of DT diaphorase could explain the effect of khellin on cytosolically activated 2-AA.
However, khellin was also capable of reducing the mutagenic effect of 2-AA drastically when S9 from uninduced liver was used for activation. After PB-induced activation of 2-AA a weak inhibition of mutagenicity by khellin was observed, in contrast to 2-AF (PB-induced activation). This may be an indication that microsomal activation proceeds not only via cytochrome P450 enzymes. Steele and Ioannides (1986) reported that uninduced S9 has a great capacity for activation of 2-AA, which also signifies the particular status of this promutagen. However, considering the great variation in inhibitory potency of khellin against the promutagens examined, an important crucial point may be that the various inducers activate cytochrome P-450 sub-enzymes to different degrees and also alter the ratio between the activation and deactivation processes. MC specifically induces the P450 I family (McManus and McKinnon, 1991) . Owing to this, khellin had a limited inhibitory effect. PB, however, mainly induces the P450 IIB sub-family and the sub-enzymes of this family seemed to be more affected by khellin. Although BNF induces the same cytochrome P450 family as MC, the inhibitory potency of khellin varied markedly in the case of B[a]P activation. This finding needs further clarification.
The results obtained with the extract differ at least quantitatively from that of khellin. Although the other furanochromones tested were toxic or inactive, synergistic or additive effects of accompanying compounds could explain the higher effect of the extract. However, we cannot exclude the possibility that additional inhibitors exist in the extract. Possible candidates are pyranocoumarins, e.g. visnadin, or simple coumarins. Visnadin was tested against 2-AA and exihibited only weak inhibitory effects (1000 \ig/ plate produced 29% inhibition). No attempt was made to examine the coumarins in the extract, but it is known from the literature that coumarins inhibit 2-AA induced mutagenicity (Ernster et al., 1962; Wall et al., 1988) . As indicated from fractionation experiments, the main activity of the extract was concentrated in the petroleum ether fraction, in which khellin, visnagin and visnadin, but no other components, could be identified by TLC using authentic references.
